Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


A Whistle-Stop Tour of 2017 – From An EU Regulatory Point Of View

Executive Summary

This past year was a busy one for regulators and regulated alike in the EU. We take a look at some of the key events from 2017.


Related Content

Pharma Struggling To Assimilate Flood Of Clinical Trial Data
EMA Ends Year With Set of Straight Noes For PRIME Applicants
Enhanced EudraVigilance System Goes Live, EMA Updates Info For Users
US FDA Recognizes Eight EU Authorities, Triggers Mutual Recognition Provisions
EMA's Proposal To Disclose Key Elements Of Pediatric Plans On Hold For Now
EMA Urged To Do Better On Valproate Risk Reduction In Pregnant Women


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts